Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.
Clinical trial NCT01120093 · COMPLETED
Trial details
- NCT number
- NCT01120093
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-08-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.